Ergomed Appoints Andrew Mackie as Chief Business Officer
July 02 2015 - 3:48AM
Dow Jones News
LONDON-- Pharmaceutical services group Ergomed PLC (ERGO.LN)
Thursday announced the appointment of Andrew Mackie, who has held
senior research and development roles at pharma companies including
Novartis AG (NVS) and Sanofi (SNY), as Chief Business Officer and
executive director, effective from 1 July 2015.
Shares at 0717 GMT, unchanged at 180 pence valuing the company
at GBP51.6 million.
-Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter:
@RoryGallivan
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2023 to Apr 2024